参考文献/References:
[1] Lévesque D,Siaz J,Pilon C, et al. Identification,characterization,and localization of the dopamine D3 receptor in rat brain using 7-[3H] hydroxy-N,N-di-n-propyl-2-aminotetralin[J].Proc Natl acad Sci,1992,89:8155-8159.
[2] Gonzalez AM,Sibley D R. [3H] 7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors[J].Eur J Pharmacol,1995,272:R1-R3.
[3] Damsma G,Bottema T,Weserink B H C, et al. Pharmacological aspects of R-(+)-7-OH-DPAT,a putative dopamine D3 receptor ligand[J].Eur J Pharmacol,1993,249:R9.
[4] Van Vliet A,Tepper PG,Dijkstra D, et al. Affinity for Dopamine D2,D3 and D4 Receptors of 2-aminotetrahns relevance of D2 agonist binding for determination of receptor subype selectivity[J].J Med Chem,1996,39,4233-4237.
[5] Wallace DR,Booze RM. Identification of D3 and σ receptors in the rat striatum and nucleus accumbens using(±)-7-Hdroxy-N,N-Di-n-[3H] Propyl-2-aminotetralin and carbetapentane[J].J Neurochem,1995,64:700-710.
[6] Foulon C,Kung MP,Kung HF, et al. Synthesis of(R S)-2’-trans-7-hydroxy-2-[N-(3’-iodo-2’-prope-nyl)-N-n-propyl] Aminotetralin(trans-7-OH-PIPAT)[J].J Med Chem,1994,36:1499-1500.
[7] Chumpradit S,Kung M P,Kung H F, et al. Synthesis and optical resolution of(R)-and(S)-trans-7-Hydroxy-2-[N-propyl-N-(3’-iodo-2’-propenyl)amino] tetralin:a new D3 Dopamine Receptor Ligand[J].J Med Chem,1993,36:4308-4312.
[8] Kung MP,Kung H F,Foulon C, et al. In Vitro Binding of a Novel Dopamine D3 Receptor Ligand:[125I] trans-7-OH-PIPATA[J].Eur J Pharmacol,1993,235:165-166.
[9] Burris KD,Filtz T,Chumpradit S, et al. Characterization of[125I] -(R)-2’-trans-7-Hydroxy-2-[N-n-Propyl-N-(3’-iodo-2’-propenyl)amino] tetralin([125I] (R) trans-7-OH-PIPAT) binding to dopamine D3 receptors in rat olfactory tubercle[J].J Pharmacol Exp Ther,1994,268,935-942.
[10] Chumpradit S,Kung MP,Vessotskie J, et al. Iodinated 2-aminotetralins and 3-Amino-l-benzopyrans:Ligands for dopamine D2 and D3 receptors[J].J Med Chem,1994,37,4245-4250.
[11] Vessotskie J,Kung MP,Chumpradit S, et al. Quantitative autoradiographie studies of dopamine D3 receptors in rat cerebellum using [125I] S(-)5-OH-PIPAT[J].Brain Res,1997,778:89-98.
[12] Avenell KY,Boyfield I,Coldwell M C, et al. Fused aminotetralins:Novel antagonists with high selectivity for the dopamine D3 receptor[J].Bioorg Med Chem Letts,1998,8:2859-2864.
[13] Austin NE,Avenell KY,Boyfield I, et al. Design and Synthesis of Novel 2,3-Dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor[J].Bioorg Med Chem Letts,2001,11:685-688.
[14] Akunne HC,Towers P,Ellis GJ, et al. Characterization of binding of [3H] PD128907,a selective dopamine D3 receptor agonist ligand,to CHO-K1 Cells[J].Life Sci,1995,57(15):1401-1410.
[15] Millan MJ,Audinot V,Rivet J, et al. S14279,A novel,selective ligand at cloned dopamine D3 receptors,blocks 7-OH-DPAT-indueee hypothermia in rats[J].Eur J Pharmacol,1994,260,R3-R5.
[16] Rivet JM,Audinot V,Gobert A, et al. Modulation of mesolimbie dopamine release by the selective dopamine D3 receptor antagonist,(+)S14297[J].Eur J Pharmacol,1994,265:175-177.
[17] Mierau J,Schneider FJ,Ensinger HA, et al. Pramipexole binding and activation of cloned and expressed dopamine D2,D3 and D4 receptors[J].Eur J Pharmacol-Mol Pharmacol Sec,1995,290,29-36.
[18] Wallace DR,Booze RM. Pramipexole,a dopamine D2-preferring compound that lacks interactions with sigma binding sites[J].Neurosci Res Commun,1995,17:177.
[19] Piereey MF,Walker EL,Feldpauseh DL, et al. High affinity binding for pramipexole,a dopamine D3 receptor ligand in rat striatum[J].Neurosci Lett,1996,219,138-140.
[20] Murray PJ,Harrison LA,Johnson MR, et al. A novel series of Arylpiperazines with high affinity and selectivity for the dopamine D3 receptor[J].Bioorg Med Chem Lett,1995,5(3):219-222.
相似文献/References:
[1]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[2]蔡莉,高硕.PET在精神分裂症中的研究进展[J].国际放射医学核医学杂志,2011,35(2):69.[doi:10.3760/cma.j.issn.1673-4114.2011.02.002]
CAI Li,GAO Shuo.Progress of PET imaging in Schizophrenia[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(2):69.[doi:10.3760/cma.j.issn.1673-4114.2011.02.002]
[3]宁艳丽,晋建华.癫痫脑内相关受体改变及其PET研究[J].国际放射医学核医学杂志,2009,33(2):65.[doi:10.3760/cma.j.issn.1673-4114.2009.02.001]
NING Yan-li,JIN Jian-hua.Study progress on related receptor changes and PET of epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):65.[doi:10.3760/cma.j.issn.1673-4114.2009.02.001]
[4]赵娟,刘兴党.实验性近视眼视网膜多巴胺神经系统研究进展[J].国际放射医学核医学杂志,2007,31(2):73.
ZHAO Juan,LIU Xing-dang.Study and development of retinal dopamine nervous system in experimental myopia[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(2):73.
[5]原凌,刘建中,武志芳.SPECT脑血流灌注显像和受体显像对抑郁症的研究[J].国际放射医学核医学杂志,2007,31(5):277.
YUAN Ling,LIU Jian-zhong,WU Zhi-fang.The study of SPECT cerebral blood flow and neuroreceptor imaging in depressive disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(2):277.
[6]刘淼,刘兴党.视网膜神经受体及其分子显像研究进展[J].国际放射医学核医学杂志,2017,41(5):359.[doi:10.3760/cma.j.issn.1673-4114.2017.05.010]
Liu Miao,Liu Xingdang.Review of retinal receptors and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(2):359.[doi:10.3760/cma.j.issn.1673-4114.2017.05.010]
[7]张旭光.局部注射放射性核素治疗实体瘤的探讨[J].国际放射医学核医学杂志,2002,26(3):105.
ZHANG Xu-guang.Probe into intratumoral injection of radionuclide treating solid tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(2):105.